Back to search

Democritus University of Thrace (DUTH)

Μελέτη του ρόλου των Τ ρυθμιστικών λεμφοκυττάρων στην παθογένεια των μυελοδυσπλαστικών συνδρόμων

Abstract

dc:description

Myelodysplastic syndromes (MDS) comprise of a heterogeneous group of diseases which evolve from a clonal stem-cell haematopoietic disorder and are accompanied by immune disorders. Several lines of evidence suggest that immune deregulation in these disorders evokes autoimmune manifestations in the bone marrow, such as clonal T-cell expansions and elevated proinflammatory cytokine levels. The effect of immune deregulation is more profound in the early stages. Autoimmune manifestations lead to bone marrow failure, peripheral cytopenias and, finally, to systemic autoimmunity in up to 30% of the cases. Contrary to the early stages, progression of MDS is characterized by the immune evasion and selective growth advantage of the malignant clone. CD4+CD25+FOXP3+ T regulatory (Tregs) cells maintain immunological tolerance by actively suppressing immune responses. Increased Treg activity may protect from autoimmunity, but impairs immune surveillance and anti-tumour immune responses. On the other hand, reduced Treg activity is associated with development of autoimmunity and more effective immune surveillance. The co-existence of malignancy with autoimmunity and immune-mediated bone marrow failure in MDS led us to the hypothesis that these two distinct processes might be subject to aberrant immune regulation by Tregs. Considering the major role that Tregs play in regulating immune responses as well as the involvement of the immune system in MDS pathogenesis, the purpose of this study was to thoroughly investigate Treg dynamics and function in MDS patients of both early and late stages of the disease. Initially, Treg number, frequency and function were studied in both peripheral blood and bone marrow. Subsequently, differences in chemokine receptor profile of Tregs were addressed along with their migration potential. Finally, Treg number was monitored during disease progression and response to chemotherapy. PATIENTS AND METHODS: Treg number and frequency as well as CXCR4 expression were assessed by flow cytometry in peripheral blood (PB) and bone marrow (BM) of early-stage (E-MDS, n=44) and late-stage MDS patients (L-MDS, n=19). The control group was comprised of 28 haematologically normal age-matched individuals (Normal), 14 of whom had undergone orthopaedic surgery. Treg function was evaluated by proliferation/suppression assays performed with magnetically isolated CD4+CD25- and CD4+CD25high cells after polyclonal stimulation with soluble CD3/CD28 beads. IFN-γ and TNF-α levels were determined in the supernatants of the proliferation/suppression assays by flow cytometry, using CBA (Cytometric Bead Array) method, while CXCL12 and TNF-α were detected by ELISA in bone marrow fluid and serum. The significance of the differences was assessed by one-way ANOVA or paired Student’s t test as appropriate. RESULTS: CD4+CD25+FOXP3+ Treg number and frequency in PB as well as Treg frequency in BM of L-MDS patients displayed a more than two-fold increase compared to both normal individuals and E-MDS patients. No difference was detected between controls and E-MDS patients. A significant Treg expansion was observed during disease progression, where Treg number in PB followed tumour burden fluctuations prior to and after response to chemotherapy. Finally, both in PB and BM, the naive CD45RA+ Tregs were predominantly expanded in L-MDS. As far as Treg function is concerned, Tregs of E-MDS patients exerted a defective suppressive capacity both in PB and BM. In particular, in E-MDS patients, Tregs were less effective in suppressing autologous polyclonal T-cell proliferative responses compared to normal individuals and L-MDS patients. Furthermore, measurement of IFN-γ and TNF-α concentrations yielded comparable results with the in vitro proliferation of T effector cells. Tregs from E-MDS patients failed to suppress IFN-γ and TNF-α production from autologous CD4+CD25- cells both in PB and BM compared to normal controls and L-MDS patients. Regarding the Treg migratory properties, CXCR4 expression was reduced in PB Tregs of E-MDS patients compared to normal individuals and L-MDS patients. In accordance to this finding, PB Tregs from E-MDS patients exhibited decreased in vitro chemotaxis compared to normals and L-MDS patients. On the contrary, Tregs from normal and L-MDS patients displayed comparable CXCR4 expression and chemotaxis. Moreover, in vitro chemotaxis was similar to all three study groups when normal PB Tregs migrated towards bone marrow fluid of patients and normal controls. Finally, BM Treg frequency levels in E-MDS patients were significantly decreased compared to PB, while normal controls and L-MDS patients exerted no difference between these two compartments. CONCLUSIONS: In conclusion, this study indicates the involvement of Tregs in the pathophysiology of MDS. The numerical and functional defects of Tregs at the early stages of the disease, where autoimmune manifestations are prominent, as well as the Treg expansion followed by recovery of their function in the late stages, where tumour escape is dominant, imply a link between Treg impairment and MDS pathophysiology. This hypothesis is reinforced by the fact that Treg number fluctuates according to disease stage. Given the effectiveness of immunosuppressive regimens in MDS and the encouraging results of the regulatory T-cell immunotherapy in solid neoplasms and autoimmune conditions, the findings of this study set the scene for the incorporation of the therapeutic manipulation of Tregs in MDS.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bouchliou, Irene
  • Μπουχλίου-Κουλίση, Ειρήνη

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25665

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bouchliou, Irene; Μπουχλίου-Κουλίση, Ειρήνη. Μελέτη του ρόλου των Τ ρυθμιστικών λεμφοκυττάρων στην παθογένεια των μυελοδυσπλαστικών συνδρόμων. Democritus University of Thrace (DUTH), 2011. http://hdl.handle.net/10442/hedi/25665